For ten years Relenza has been on the back foot because of GSK. Do you know how close it came to GSK giving Relenza back to BTA because they hated relenza so much. One or two days. They dispised it so much they where going to hand to over for nothing. Its all in the evidence GSK provided for the court case.
GSK wanted to develop vacinnes not antivirals. MORE MONEY IN IT. PC capitulated. It's a crying shame that will never be forgotten by loyal BTA holders.
DYOR
BTA Price at posting:
$1.38 Sentiment: ST Buy Disclosure: Held
